A 42-year-old woman with acute pancreatitis develops hypovolemic shock after 48 hours of inadequate fluid intake and significant third-space losses. Regarding the management and pathophysiology of hypovolemic shock, all of the following statements are true EXCEPT:

Explanation

## Hypovolemic Shock Management — Fluid Resuscitation Hierarchy ### The Correct Answer: Colloids Are NOT Superior to Crystalloids **Key Point:** Multiple large RCTs (SAFE trial, ALBUR trial) have demonstrated that **colloids (albumin, dextran, gelatin) are NOT superior to crystalloids** in reducing mortality in hypovolemic shock. Crystalloids remain the first-line fluid of choice, with colloids reserved for specific scenarios (e.g., severe hypoproteinemia <5 g/dL in liver disease). **High-Yield:** The SAFE trial (2004) showed no mortality difference between albumin and crystalloid in hypovolemic shock, making crystalloid the cost-effective, evidence-based choice. ### Why the Other Options Are Correct | Statement | Evidence | |-----------|----------| | **Crystalloid first-line** | Normal saline or Ringer's lactate; target urine output 0.5 mL/kg/hr (non-renal patients); 1 mL/kg/hr in renal patients | | **Shock phases** | Compensatory (tachycardia, vasoconstriction, normal BP) → Decompensatory (hypotension, organ dysfunction, irreversible if prolonged) | | **Vasopressor timing** | Withheld until adequate volume repletion; premature vasopressor use worsens tissue perfusion in hypovolemic shock | ### Pathophysiology Timeline ```mermaid flowchart TD A[Hypovolemia]:::outcome --> B[Compensatory Phase]:::outcome B --> C[↑ Sympathetic tone<br/>↑ HR, ↑ SVR<br/>Normal BP]:::outcome C --> D{Adequate fluid<br/>resuscitation?}:::decision D -->|Yes| E[Recovery]:::action D -->|No| F[Decompensatory Phase]:::urgent F --> G[↓ BP, ↓ CO<br/>Tissue hypoxia<br/>Organ dysfunction]:::urgent G --> H[Irreversible shock<br/>MODS, Death]:::urgent ``` ### Clinical Pearl **Warning:** Do NOT use colloids as first-line in hypovolemic shock. The SAFE trial definitively showed no survival benefit. Colloids are 5–10× more expensive and increase risk of hyperchloremic acidosis (normal saline) or coagulopathy (dextran). Reserve colloids for: - Severe hypoproteinemia (<5 g/dL) in cirrhosis - Massive transfusion protocols (FFP, cryoprecipitate) - Specific ICU protocols for refractory hypotension after adequate crystalloid **Mnemonic — HYPOVOLEMIC SHOCK FLUIDS (HSF):** - **H**igh-volume crystalloid first (30 mL/kg bolus) - **S**aline or Ringer's lactate preferred - **F**luids before pressors (fill the tank first) - **L**actate clearance monitored (marker of perfusion) - **U**rine output target: 0.5 mL/kg/hr - **I**ntake–output balance tracked - **D**extran/albumin: NOT first-line **Tip:** In NEET PG, remember: **Crystalloid > Colloid** in hypovolemic shock. Colloids do NOT reduce mortality and are more expensive.